Up-regulation of plasminogen activator inhibitor-2 is associated with high-risk HPV and grade of cervical lesion at baseline but does not predict outcomes of high-risk HPV infections or incident CIN

American Journal of Clinical Pathology
Stina SyrjänenKari Syrjänen

Abstract

Protease inhibitor serpin-B2 (plasminogen activator inhibitor-2 [PAI-2]) protects pRb from degradation in human papillomavirus (HPV)-18+ HeLa cells. Our objective was to assess whether the pRb-mediated HPV-suppressive effect of PAI-2 in cancer cell lines has implications in the outcome of HPV infections. Cervical biopsy specimens from 225 women were analyzed for PAI-2 expression to assess its value as a predictor of cervical intraepithelial neoplasia (CIN) grade, high-risk (HR) HPV at baseline, outcomes of HR-HPV infections, and the development of incident CIN. PAI-2 expression increased in parallel with lesion grade. Nuclear PAI-2 expression was significantly related to HR-HPV detection and had a linear relationship with HR-HPV load. PAI-2 expression was of no value in predicting the outcomes of HR-HPV infections. The same was true for PAI-2 as a predictor of surrogate end points (incident CIN 1+, CIN 2+) of progressive disease. PAI-2 expression is up-regulated on transition from CIN 2 to CIN 3. The HR-HPV suppressive effects of PAI-2 were not related to more favorable outcomes of HR-HPV infections or lower risk of disease progression to CIN.

References

Jan 1, 1988·International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists·S SyrjänenR Mäntyjärvi
Nov 1, 1989·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·K J Syrjänen
Aug 8, 1998·Trends in Cell Biology·X Tan, J Y Wang
Aug 12, 1999·Annals of Medicine·S M Syrjänen, K J Syrjänen
Jul 19, 2000·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·K KurvinenS Syrjänen
Feb 23, 2002·European Journal of Obstetrics, Gynecology, and Reproductive Biology·M ErzenK Syrjänen
Nov 21, 2002·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·M von Knebel Doeberitz
Feb 4, 2003·Nature Reviews. Cancer·B Nelson Chau, Jean Y J Wang
Feb 7, 2003·The New England Journal of Medicine·Nubia MuñozUNKNOWN International Agency for Research on Cancer Multicenter Cervical Cancer Study Group
Feb 3, 2004·Current Pharmaceutical Design·Michael J Duffy
Sep 24, 2004·International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists·M BrancaK Syrjänen
Oct 14, 2004·Journal of Virology·Karl MüngerKyungwon Huh
Nov 24, 2004·Cellular and Molecular Life Sciences : CMLS·H Myöhänen, A Vaheri
Jun 29, 2006·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·A Longatto-FilhoK Syrjänen
Jul 13, 2006·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Rosa SantopietroStina Syrjänen
Aug 22, 2006·Gynecologic Oncology·Magnus von Knebel-Doeberitz, Kari J Syrjänen
Aug 29, 2006·Oncogene·W Du, J Pogoriler
Sep 23, 2006·International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists·Margherita BrancaUNKNOWN HPV-PathogenISS Study Group
Aug 19, 2007·The Biochemical Journal·David R CroucherMarie Ranson
Mar 5, 2008·International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists·Margherita BrancaUNKNOWN HPV-PathogenISS Study Group
Jun 13, 2008·Nature Reviews. Cancer·David R CroucherMarie Ranson
Jul 18, 2008·Cancer Research·Laura TonnettiToni M Antalis
Jul 4, 2009·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Kari SyrjänenUNKNOWN New Independent States of the Former Soviet Union and the Latin American Screening Study Research Groups

❮ Previous
Next ❯

Citations

Nov 4, 2011·Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire·Brigitte GouletJohn D Lewis

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bowen's Disease

Bowen's disease is thought of as an easily-treatable early stage of skin cancer, characterized by red, scaly patches on the skin. Discover the latest research on Bowen's disease here.